SEP 07, 2016 12:00 PM PDT

Cord Blood Compound To Treat Inflammation

WRITTEN BY: Kara Marker
A compound found in newborns is thought to have the ability to treat excessive inflammation, which could be lifesaving in cases of sepsis. However, the compound disappears from newborn circulation after two weeks of life. 
Infection fighting cells from umbilical cord blood (left) and circulating blood three days after birth (right) from the same prematurely born baby.
First found in umbilical cord blood, the compound works by inhibiting the production of neutrophil extracellular traps (NETs). Thus, the compound is reasonably referred to as neonatal NET inhibitor factor, or nNIF. 

NETs have the ability to damage blood vessels and organs during sepsis, but their intended role is simply to protect the body from pathogens. While a healthy person might have normal-functioning NETs, a person exposed to nicotine from cigarette smoke or someone with sepsis could contain the types of NETs that malfunction, causing excessive inflammatory damage. As for nicotine exposure, the chemical stimulates neutrophils to release NETs and reactive oxygen species. In the present study, researchers think that inhibiting NETs when they “go rogue” might help treat sepsis.

"nNIF is offering insights into how to keep the inflammatory response within prescribed limits,” said lead author Christian Con Yost, MD.

After understanding the ability of nNIFs to inhibit the production NETs, scientists from the University of Utah set out to conduct further tests confirming nNIFs’ ability to control sepsis. Using groups of mice models of sepsis, all from different causes, the researchers used nNIFs to see if they could heal some of the mice. Only 20 mice survived longer than a couple of days without nNIF treatment, but the mice who did receive nNIF were three times as likely to survive.

It makes sense that nNIF remains in the circulation of newborns, because the first weeks after birth a newborn’s immune system is still building up strength and the gut microbiome is only starting to grow. Yost said that the “transient nature” of nNIF in newborn blood is connected to the tight control of inflammation during the first two weeks of a newborn’s life, certainly a vulnerable time.

"The beginning of life is a delicate balance," Yost said. "Our work is showing that it is important to have the right defenses, but they have to be controlled."

The placenta has a similar compound to nNIF, but it’s less potent. 

The current study was recently published in The Journal of Clinical Investigation.
 


Source: University of Utah Health Sciences
Image: Mark Cody/Diana Lim
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 04, 2021
Immunology
Climate Change Tightens Its Grip on Hay Fever Sufferers
MAR 04, 2021
Climate Change Tightens Its Grip on Hay Fever Sufferers
There’s bad news for pollen allergy sufferers: New research has shown that climate change is making hay fever seas ...
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
MAR 11, 2021
Immunology
Bye-Bye Burning: A New UTI Vaccine
MAR 11, 2021
Bye-Bye Burning: A New UTI Vaccine
Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
MAY 03, 2021
Immunology
Junk Food Helps Bad Bacteria Thrive In the Gut, Promotes Inflammation
MAY 03, 2021
Junk Food Helps Bad Bacteria Thrive In the Gut, Promotes Inflammation
We know that processed foods like ice cream, potato chips, and candy bars in excess can cause people to pile on the poun ...
JUN 15, 2021
Clinical & Molecular DX
An Early Warning System for Type 1 Diabetes in Children
JUN 15, 2021
An Early Warning System for Type 1 Diabetes in Children
In type 1 diabetes, or T1D, the body’s own immune system mistakenly launches an aggressive attack on insulin-produ ...
Loading Comments...